\-\ Texto\\:\\ \ \(0\)\
\-\ surgical\\ excision\\ with\\ chemotherapy\\ and\\ continuation\\ of\\ regular\\ screening\\ exams\\.\ \(0\)\
\-\ there\\ is\\ a\\ mass\\ in\\ the\\ central\\ portion\\ of\\ the\\ left\\ kidney\\ that\\ is\\ hypoenhancing\\ relative\\ to\\ the\\ normal\\ renal\\ parenchyma\\.\\ \\ the\\ kidney\\ itself\\ is\\ markedly\\ enlarged\\ with\\ severe\\ calyceal\\ dilation\\.\\ \\ the\\ right\\ kidney\\ has\\ post\\-surgical\\ changes\\ in\\ the\\ inferior\\ pole\\ consistent\\ with\\ prior\\ wilm\\â\\€\\™s\\ tumor\\ extraction\\.\\ \\ there\\ is\\ no\\ evidence\\ of\\ \\ vascular\\ invasion\\ or\\ para\\-aortic\\ lymphadenopathy\\ and\\ the\\ remainder\\ of\\ the\\ abdomen\\ appears\\ grossly\\ normal\\.\ \(0\)\
\-\ wilms\\ tumor\\ in\\ the\\ setting\\ of\\ known\\ nephroblastomatosis\ \(0\)\
\-\ wilms\\ tumor\ \(0\)\
\-\ neuroblastoma\ \(81\)\
\-\ lymphoma\ \(373\)\
\-\ rhabdomyosarcoma\ \(41\)\
\-\ the\\ patient\\ is\\ an\\ asymptomatic\\ 5\\-year\\-old\\ male\\ who\\ presents\\ with\\ a\\ known\\ history\\ of\\ nephroblastomatosis\\ and\\ prior\\ right\\-sided\\ wilm\\'s\\ tumor\\ for\\ a\\ routine\\,\\ screening\\ abdominal\\ mri\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ wilm\\:\\ 0\\.10991373239857896\ \(0\)\
\-\ nephroblastomatosis\\:\\ 0\\.1077772301165866\ \(0\)\
\-\ wilms\\:\\ 0\\.08462652638960538\ \(0\)\
\-\ kidney\\:\\ 0\\.07224920292120024\ \(0\)\
\-\ 5\\-year\\-old\\:\\ 0\\.06497896994725243\ \(0\)\
\-\ tumor\\:\\ 0\\.06375143365154597\ \(0\)\
\-\ hypoenhancing\\:\\ 0\\.059433792502772864\ \(0\)\
\-\ screening\\:\\ 0\\.058320550862853544\ \(0\)\
\-\ para\\-aortic\\:\\ 0\\.0538886150582933\ \(0\)\
\-\ continuation\\:\\ 0\\.05134098520934502\ \(0\)\
\-\ calyceal\\:\\ 0\\.048859745782914306\ \(0\)\
\-\ extraction\\:\\ 0\\.048859745782914306\ \(0\)\
\-\ post\\-surgical\\:\\ 0\\.04445937508756013\ \(0\)\
\-\ known\\:\\ 0\\.04326481735142112\ \(0\)\
\-\ exams\\:\\ 0\\.03861227501921779\ \(0\)\
\-\ itself\\:\\ 0\\.038465481909872215\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.038465481909872215\ \(0\)\
\-\ grossly\\:\\ 0\\.03587828066944134\ \(0\)\
\-\ prior\\:\\ 0\\.035105804355237816\ \(0\)\
\-\ setting\\:\\ 0\\.034525670029089864\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.03417778913357196\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.03336902019860101\ \(0\)\
\-\ invasion\\:\\ 0\\.03292030446539265\ \(0\)\
\-\ relative\\:\\ 0\\.03256469036482599\ \(0\)\
\-\ markedly\\:\\ 0\\.032358670396006664\ \(0\)\
\-\ dilation\\:\\ 0\\.03222421344947562\ \(0\)\
\-\ remainder\\:\\ 0\\.03222421344947562\ \(0\)\
\-\ pole\\:\\ 0\\.031833892136120166\ \(0\)\
\-\ regular\\:\\ 0\\.031522568806122774\ \(0\)\
\-\ parenchyma\\:\\ 0\\.029114949531141354\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.029069878989395306\ \(0\)\
\-\ excision\\:\\ 0\\.028058005812522345\ \(0\)\
\-\ routine\\:\\ 0\\.02741157355319998\ \(0\)\
\-\ appears\\:\\ 0\\.02544583056637799\ \(0\)\
\-\ portion\\:\\ 0\\.024761653178872692\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02450356628112692\ \(0\)\
\-\ enlarged\\:\\ 0\\.023324968563072052\ \(0\)\
\-\ inferior\\:\\ 0\\.023194530890872502\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.023108739183968698\ \(0\)\
\-\ central\\:\\ 0\\.022493050854879675\ \(0\)\
\-\ is\\:\\ 0\\.022491631135389024\ \(0\)\
\-\ vascular\\:\\ 0\\.022414426143389572\ \(0\)\
\-\ normal\\:\\ 0\\.021433799273585616\ \(0\)\
\-\ severe\\:\\ 0\\.021034478400528033\ \(0\)\
\-\ renal\\:\\ 0\\.020539804395664555\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.020432213917163648\ \(0\)\
\-\ there\\:\\ 0\\.02034744890343982\ \(0\)\
\-\ abdomen\\:\\ 0\\.02025107410316557\ \(0\)\
\-\ s\\:\\ 0\\.019606141336916696\ \(0\)\
\-\ changes\\:\\ 0\\.019592383809880484\ \(0\)\
\-\ lymphoma\\:\\ 0\\.019537589075115887\ \(0\)\
\-\ evidence\\:\\ 0\\.017923540666935023\ \(0\)\
\-\ who\\:\\ 0\\.017823747273133617\ \(0\)\
\-\ abdominal\\:\\ 0\\.017087353904976923\ \(0\)\
\-\ consistent\\:\\ 0\\.016762386150649625\ \(0\)\
\-\ mri\\:\\ 0\\.01570620683931696\ \(0\)\
\-\ \\'s\\:\\ 0\\.01507237294693636\ \(0\)\
\-\ surgical\\:\\ 0\\.014369774162011628\ \(0\)\
\-\ presents\\:\\ 0\\.013965154364063407\ \(0\)\
\-\ has\\:\\ 0\\.012837599763954224\ \(0\)\
\-\ male\\:\\ 0\\.012361644303099786\ \(0\)\
\-\ that\\:\\ 0\\.011807845828470586\ \(0\)\
\-\ the\\:\\ 0\\.011059942776290063\ \(0\)\
\-\ in\\:\\ 0\\.010113533523366119\ \(0\)\
\-\ a\\:\\ 0\\.00951839524364643\ \(0\)\
\-\ mass\\:\\ 0\\.009507688055580516\ \(0\)\
\-\ an\\:\\ 0\\.00945331891427784\ \(0\)\
\-\ history\\:\\ 0\\.009441716301656668\ \(0\)\
\-\ or\\:\\ 0\\.00801218199170966\ \(0\)\
\-\ left\\:\\ 0\\.007648842154183318\ \(0\)\
\-\ right\\:\\ 0\\.007213053672883334\ \(0\)\
\-\ no\\:\\ 0\\.006883553205630416\ \(0\)\
\-\ patient\\:\\ 0\\.006852735447331104\ \(0\)\
\-\ for\\:\\ 0\\.005832865189141721\ \(0\)\
\-\ of\\:\\ 0\\.005592182438303445\ \(0\)\
\-\ and\\:\\ 0\\.004320216137573243\ \(0\)\
\-\ with\\:\\ 0\\.0037441336348764715\ \(0\)\
\-\ to\\:\\ 0\\.00341654486754389\ \(0\)\
\-\ \\,\\:\\ 0\\.0021656805241382993\ \(0\)\
\-\ \\.\\:\\ 0\\.0017039777326726213\ \(0\)\
